Skip to content
Myhep

Mylan

Myhep


MYHEP contains Drug / Molecule called “SOFOSBUVIR”. It is the first-in-class NS5B polymerase inhibitor for hepatitis C treatment and represents a paradigm shift in the existing hepatitis C management. It is highly potent, with good safety profile and the limited drug-drug interactions of sofosbuvir makes it a breakthrough drug in hepatitis C treatment.


Indication

Myhep is used for treatment of Hepatitis C.

Note

Precaution

  • Myhep (sofobuvir) is a prescription drug and should be used under proper medical guidance and advice.
  • Extreme caution must be taken to avoid pregnancy.

 

Updated On Oct 17, 2019 by Admin

Strength

400 mg

Packing

1 x 28 Tablets (Bottle)

Storage

Store at room temperature 25°C.



Related Products


NATCO PHARMA LIMITED (INDIA)

Velpanat

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

Hetero Healthcare Ltd. (INDIA)

Ledifos

Mylan

Mydacla


Most Viewed Products


CIPLA LTD. (INDIA)

Abiraterone acetate-xbira

NATCO PHARMA LIMITED (INDIA)

Bendamustine-bendit

CIPLA LTD. (INDIA)

Bicalutamide-cassotide

NATCO PHARMA LIMITED (INDIA)

Bortezomib-bortenat

NATCO PHARMA LIMITED (INDIA)

Erlonat

Biocon Limited

Everolimus-evertor

NATCO PHARMA LIMITED (INDIA)

Exemestane-xtane

NATCO PHARMA LIMITED (INDIA)

Geftinat

NATCO PHARMA LIMITED (INDIA)

Glatiramer acetate-glatimer

NATCO PHARMA LIMITED (INDIA)

Ledipasvir & sofosbuvir-hepcinat lp

NATCO PHARMA LIMITED (INDIA)

Lenalidomide-lenalid

NATCO PHARMA LIMITED (INDIA)

Pomalidomide-pomalid

NATCO PHARMA LIMITED (INDIA)

Sofosbuvir & velpatasvir-velpanat

NATCO PHARMA LIMITED (INDIA)

Sorafenib-sorafenat

CIPLA LTD. (INDIA)

Tenofovir-tenvir

Quick Query

Direct to your Phone